Related Experiment Video
Updated: Jun 3, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Rho kinase inhibitors stimulate the migration of human cultured osteoblastic cells by regulating actomyosin activity
Xuejiao Zhang1, Cheng Li, Huiling Gao
1Department of Anatomy and Embryology, Ehime University Graduate School of Medicine, Ehime, Japan.
Abstract:
We investigated the effects of Rho-associated kinase (ROCK) on migration and cytoskeletal organization in primary human osteoblasts and Saos-2 human osteosarcoma cells. Both cell types were exposed to two different ROCK inhibitors, Y-27632 and HA-1077. In the improved motility assay used in the present study, Y-27632 and HA-1077 significantly increased the migration of both osteoblasts and osteosarcoma cells on plastic in a dose-dependent and reversible manner. Fluorescent images showed that cells of both types cultured with Y-27632 or HA-1077 exhibited a stellate appearance, with poor assembly of stress fibers and focal contacts. Western blotting showed that ROCK inhibitors reduced myosin light chain (MLC) phosphorylation within 5 min without affecting overall myosin light-chain protein levels. Inhibition of ROCK activity is thought to enhance the migration of human osteoblasts through reorganization of the actin cytoskeleton and regulation of myosin activity. ROCK inhibitors may be potentially useful as anabolic agents to enhance the biocompatibility of bone and joint prostheses.
Insights
Rho-associated kinase (ROCK) inhibitors significantly boosted human osteoblast and osteosarcoma cell migration. This suggests ROCK inhibitors could improve bone prostheses biocompatibility by enhancing cell movement and cytoskeletal organization.
Area of Science:
- Cell Biology
- Biochemistry
- Orthopedics
Background:
- Rho-associated kinase (ROCK) plays a role in cellular processes like migration and cytoskeletal organization.
- Understanding ROCK's function in bone cells is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the effects of ROCK inhibition on the migration and cytoskeletal organization of primary human osteoblasts and Saos-2 osteosarcoma cells.
- To evaluate the potential of ROCK inhibitors as anabolic agents for bone prostheses.
Main Methods:
- Primary human osteoblasts and Saos-2 cells were treated with ROCK inhibitors (Y-27632 and HA-1077).
- Cell migration was assessed using an improved motility assay.
- Cytoskeletal organization was visualized using fluorescent imaging.
- Western blotting was employed to analyze myosin light chain (MLC) phosphorylation.
Main Results:
- ROCK inhibitors Y-27632 and HA-1077 significantly increased cell migration in a dose-dependent and reversible manner.
- Inhibition of ROCK led to a stellate cell appearance with reduced stress fiber and focal contact assembly.
- ROCK inhibitors rapidly decreased MLC phosphorylation without altering total MLC levels.
Conclusions:
- ROCK inhibition enhances human osteoblast and osteosarcoma cell migration through actin cytoskeleton reorganization and myosin activity regulation.
- ROCK inhibitors show potential as anabolic agents to improve the biocompatibility of bone and joint prostheses.
More Related Videos
Related Concept Videos
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Cell Migration
PI3K/mTOR/AKT Signaling Pathway
Cytoskeletal Coordination in Cell Migration

